Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04180943 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
A Phase 4 study of Anesthesia, Local, sponsored by Bassett Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT04180943 is a Phase 4 study of Anesthesia, Local that has completed, run by Bassett Healthcare. The registered enrollment target is 85 participants, roughly in line with the 78-participant average among 18 other Anesthesia, Local trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04180943, a Phase 4 study of Anesthesia, Local, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.
Conditions Studied
Interventions
- DRUG interscalene nerve block
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2019-12-13 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04180943
The ClinicalTrials.gov registry entry for NCT04180943 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 78-participant average among 18 other Anesthesia, Local trials with a reported enrollment target. The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 1 intervention - of which interscalene nerve block is the first listed.
NCT04180943 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04180943 about?
NCT04180943 is a clinical study titled "Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery". This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifica...
What is the current status of trial NCT04180943?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 85 participants. The study started on 2019-12-13. Estimated completion is 2021-06-01.
What conditions does trial NCT04180943 study?
This clinical trial studies the following conditions: Anesthesia, Local.
What interventions are being tested in trial NCT04180943?
The interventions under investigation include: interscalene nerve block (DRUG).
Who is sponsoring clinical trial NCT04180943?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04180943 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
-
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
RECRUITING · Phase 4
-
Intralipid® 20% for Reversal of Local Anesthetics
ACTIVE NOT RECRUITING · Phase 4
-
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.